Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Price MM et al. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. 2013 J. Allergy Clin. Immunol. pmid:22939756
Kimizuka K et al. Sphingosine 1-phosphate (S1P) induces S1P2 receptor-dependent tonic contraction in murine iliac lymph vessels. 2013 Microcirculation pmid:22913344
Yuan S et al. Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations. 2013 PLoS Comput. Biol. pmid:24098103
Gaveglio VL et al. Phosphatidic acid metabolism in rat liver cell nuclei. 2013 FEBS Lett. pmid:23439070
Wirotanseng LN et al. Gq rather than G11 preferentially mediates nociceptor sensitization. 2013 Mol Pain pmid:24156378
Kurek K et al. [The role of sphingolipids in selected cardiovascular diseases]. 2013 Postepy Hig Med Dosw (Online) pmid:24088546
Kowalski GM et al. Plasma sphingosine-1-phosphate is elevated in obesity. 2013 PLoS ONE pmid:24039766
Ohotski J et al. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer. 2013 Int. J. Cancer pmid:22733311
Chan H and Pitson SM Post-translational regulation of sphingosine kinases. 2013 Biochim. Biophys. Acta pmid:22801036
Deng H et al. Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis. 2013 ACS Med Chem Lett pmid:24900589
Zhang W et al. Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells. 2013 Prostaglandins Other Lipid Mediat. pmid:23770055
Selhub J et al. Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease. 2013 J. Nutr. Biochem. pmid:24183308
Ishii M and Kikuta J Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. 2013 Biochim. Biophys. Acta pmid:22691949
Schwalm S et al. Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases. 2013 Biochim. Biophys. Acta pmid:22889995
Tran-Dinh A et al. HDL and endothelial protection. 2013 Br. J. Pharmacol. pmid:23488589
Hardin C et al. Glassy dynamics, cell mechanics, and endothelial permeability. 2013 J Phys Chem B pmid:23638866
Schneider G et al. Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy. 2013 Mol. Cancer Res. pmid:23615526
Goyal P et al. Cytokine IL-6 secretion by trophoblasts regulated via sphingosine-1-phosphate receptor 2 involving Rho/Rho-kinase and Rac1 signaling pathways. 2013 Mol. Hum. Reprod. pmid:23538947
Cinq-Frais C et al. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1. 2013 Biochim. Biophys. Acta pmid:23651497
Christoffersen C and Nielsen LB Apolipoprotein M: bridging HDL and endothelial function. 2013 Curr. Opin. Lipidol. pmid:23652568
Egom EE et al. HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL. 2013 Curr. Opin. Lipidol. pmid:23652570
Lundblad C et al. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat. 2013 Acta Anaesthesiol Scand pmid:23683126
Kroetsch JT and Bolz SS The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure. 2013 J. Vasc. Res. pmid:23594703
Allende ML et al. Sphingosine-1-phosphate phosphatase 1 regulates keratinocyte differentiation and epidermal homeostasis. 2013 J. Biol. Chem. pmid:23637227
Schaper K et al. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. 2013 J. Dermatol. Sci. pmid:23643308
Böhm A et al. Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells. 2013 Cardiovasc. Res. pmid:23658376
Matsuzaki E et al. Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. 2013 Bone pmid:23612487
Finley A et al. Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. 2013 PLoS ONE pmid:23372844
Dusaban SS et al. Phospholipase C epsilon links G protein-coupled receptor activation to inflammatory astrocytic responses. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23401561
Kalhori V et al. Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells. 2013 PLoS ONE pmid:23824493
Guo H et al. An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. 2013 J. Neurosci. pmid:23554499
Carr JM et al. Sphingosine kinase 1 in viral infections. 2013 Rev. Med. Virol. pmid:22639116
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Sobel K et al. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling. 2013 J. Biol. Chem. pmid:23589284
Barth BM et al. Gaucher's disease and cancer: a sphingolipid perspective. 2013 Crit Rev Oncog pmid:23510065
Bernhart E et al. Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro. 2013 Exp. Cell Res. pmid:23562655
Selvam SP and Ogretmen B Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance. 2013 Handb Exp Pharmacol pmid:23563649
Pyne S and Pyne NJ New perspectives on the role of sphingosine 1-phosphate in cancer. 2013 Handb Exp Pharmacol pmid:23563651
Jiang XC and Liu J Sphingolipid metabolism and atherosclerosis. 2013 Handb Exp Pharmacol pmid:23563655
Levkau B Cardiovascular effects of sphingosine-1-phosphate (S1P). 2013 Handb Exp Pharmacol pmid:23563656
Abbasi T and Garcia JG Sphingolipids in lung endothelial biology and regulation of vascular integrity. 2013 Handb Exp Pharmacol pmid:23563658
Park K et al. Resveratrol stimulates sphingosine-1-phosphate signaling of cathelicidin production. 2013 J. Invest. Dermatol. pmid:23856934
Huang LS et al. Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. 2013 FASEB J. pmid:23315259
Lukowski ZL et al. Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model. 2013 J. Glaucoma pmid:21946553
Kihara A [Complete metabolic pathway of sphingosine 1-phosphate and its importance as a metabolic intermediate]. 2013 Seikagaku pmid:23980469
Weichand B et al. Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration. 2013 Eur. J. Immunol. pmid:23934754
Morad SA et al. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells. 2013 Biochim. Biophys. Acta pmid:23939396
Banitalebi E et al. The effect of resistance training on plasma S1P level and gene expression of S1P1,2,3 receptors in male Wistar rats. 2013 Minerva Endocrinol. pmid:24285107
Rokka J et al. 19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical. 2013 J Labelled Comp Radiopharm pmid:24285478
Kajimoto T et al. Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. 2013 Nat Commun pmid:24231649